Autor: "Winquist, Eric" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Autorzy:: Al-Ezzi EM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Zahralliyali A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.; Division of Cancer Services, Princess Alexandra Hospital, Metro South Health, Brisbane, QLD 4113, Australia.
Hamilton RJ; Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Crump M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Kuruvilla J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Wood L; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Nappi L; Department of Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC V6T 1Z1, Canada.
Kollmannsberger CK; Department of Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC V6T 1Z1, Canada.
North SA; Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Winquist E; Department of Oncology, London Health Sciences Centre, Western University, London, ON N6A 3K7, Canada.
Soulières D; Département Hématologie-Oncologie, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0C1, Canada.
Hotte SJ; Juravinski Cancer Centre, McMaster University, Hamilton, ON L8S 4L8, Canada.
Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jun 27; Vol. 30 (7), pp. 6166-6176. Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols*
Neoplasms, Germ Cell and Embryonal*/drug therapy
Male ; Humans ; Etoposide/therapeutic use ; Prognosis ; Neoplasm Recurrence, Local/drug therapy ; Canada
SCR Disease Name:: Testicular Germ Cell Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.
Autorzy:: Hannouf MB; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
Sehgal C
Cao JQ
Mocanu JD
Winquist E
Zaric GS; Pokaż więcej
Źródło:: PloS one [PLoS One] 2012; Vol. 7 (6), pp. e38557. Date of Electronic Publication: 2012 Jun 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Monoclonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*economics
Head and Neck Neoplasms/*drug therapy
Platinum/*therapeutic use
Antibodies, Monoclonal, Humanized ; Cetuximab ; Cost-Benefit Analysis ; Humans ; Models, Theoretical

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone.
Autorzy:: Saad F; University of Montreal Hospital Centre, Montreal, PQ, Canada. />Ruether D
Ernst S
North S
Cheng T
Perrotte P
Karakiewicz P
Winquist E; Pokaż więcej
Corporate Authors:: Canadian Uro-Oncology Group
Źródło:: BJU international [BJU Int] 2008 Aug 05; Vol. 102 (5), pp. 551-5. Date of Electronic Publication: 2008 May 28.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Neoplasms, Hormone-Dependent/*drug therapy
Prostatic Neoplasms/*drug therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Disease Progression ; Docetaxel ; Humans ; Male ; Middle Aged ; Mitoxantrone/administration & dosage ; Neoplasm Metastasis ; Neoplasms, Hormone-Dependent/mortality ; Pain/etiology ; Prednisone/administration & dosage ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/mortality ; Quality of Life ; Survival Analysis ; Taxoids/administration & dosage ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Winquist, Eric"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język